Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,348 | 74,852 | 73,550 | 154,171 | 735,222 |
| Marketable Securities | 11,721 | 10,513 | 8,981 | 6,649 | 171,545 |
| Receivables | 275,840 | 301,602 | 375,608 | 384,692 | 264,264 |
| Inventories | 524,107 | 553,869 | 492,345 | 517,236 | 318,166 |
| Income taxes - deferred | 97,226 | 99,994 | 88,055 | 112,813 | 98,242 |
| TOTAL | $1,124,001 | $1,094,570 | $1,101,669 | $1,261,676 | $1,622,457 |
| Non-Current Assets | |||||
| PPE Net | 683,441 | 694,440 | 696,119 | 697,415 | 444,043 |
| Investments And Advances | 70,261 | 70,015 | 73,497 | 76,377 | 66,026 |
| Intangibles | 1,522,969 | 1,567,003 | 1,610,946 | 1,669,761 | 1,041,335 |
| Other Non-Current Assets | 54,603 | 63,351 | 63,351 | 55,348 | 25,172 |
| TOTAL | $2,331,274 | $2,394,809 | $2,443,913 | $2,498,901 | $1,576,576 |
| Total Assets | $3,455,275 | $3,489,379 | $3,545,582 | $3,760,577 | $3,199,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,587 | 5,602 | 5,479 | 107,059 | 10,336 |
| Accounts payable and accrued liabilities | 371,431 | 436,776 | 429,112 | 516,875 | 253,864 |
| TOTAL | $394,943 | $459,846 | $451,639 | $689,929 | $349,778 |
| Non-Current Liabilities | |||||
| Long Term Debt | 974,342 | 974,276 | 1,074,210 | 1,124,145 | 574,078 |
| Deferred Revenues | 16,925 | 17,468 | 17,048 | 19,222 | 8,606 |
| aiOther Non-Current Liabilities | 59,746 | 53,717 | 53,686 | 4,169 | 1,853 |
| TOTAL | $1,253,336 | $1,264,637 | $1,380,067 | $1,390,260 | $678,838 |
| Total Liabilities | $1,648,279 | $1,724,483 | $1,831,706 | $2,080,189 | $1,028,616 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,629 | 103,479 | 102,530 | 102,501 | 102,468 |
| Common Shares | 373 | 372 | 369 | 369 | 368 |
| Retained earnings | 1,141,334 | 1,106,728 | 1,070,317 | 1,041,638 | 1,529,095 |
| Other shareholders' equity | 3,459 | 1,642 | 1,287 | 1,073 | 8,071 |
| TOTAL | $1,806,996 | $1,764,896 | $1,713,876 | $1,680,388 | $2,170,417 |
| Total Liabilities And Equity | $3,455,275 | $3,489,379 | $3,545,582 | $3,760,577 | $3,199,033 |